Related Experiment Videos

Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms

B Schubert1, M Fassnacht, F Beuschlein

  • 1Schwerpunkt Endokrinologie, Department of Medicine, University of Würzburg, Germany.

Abstract

Insights

Angiotensin II type 1 receptor (AT1R) and ACTH receptor expression correlate with adrenal tumor function. AT1R is the primary receptor in these tumors, suggesting shared regulatory factors.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Type 1 angiotensin II (Ang II) receptors mediate key adrenal functions like steroidogenesis.
  • Understanding Ang II receptor regulation in adrenal neoplasms is crucial.

Purpose of the Study:

  • Investigate type 1 Ang II receptor expression in adrenocortical tissues.
  • Define its regulation in adrenocortical neoplasms.
  • Compare its expression with the ACTH receptor (ACTH-R).

Main Methods:

  • Extracted Poly A RNA from tumor tissue for Northern blot analysis.
  • Performed receptor autoradiography using radiolabeled Ang II and a selective antagonist.
  • Analyzed expression in normal adrenals, cortisol-producing adenomas (CPA), aldosterone-producing adenomas (APA), nonfunctioning adenomas (NFA), and carcinomas.

Main Results:

  • Ang II type 1 receptor mRNA was significantly elevated in CPA and APA compared to normal adrenals, but low in NFA.
  • ACTH receptor mRNA showed a similar pattern, with high expression in CPA and APA, and low/absent in NFA.
  • A significant positive correlation (r = 0.692, P = 0.0019) was observed between Ang II type 1 receptor and ACTH-R mRNA levels.
  • Autoradiography confirmed predominant type 1 Ang II receptor expression in tumor tissues, mainly in the zona glomerulosa of normal adrenals.

Conclusions:

  • Ang II type 1 receptor and ACTH receptor expression are linked to the functional status of adrenocortical tumors.
  • Similar regulatory factors may control the expression of both receptors.
  • Type 1 Ang II receptor is the predominant subtype expressed in adrenocortical tumors, with minimal type 2 expression.

Related Concept Videos